Confluence Discovery Technologies is a drug discovery contract research organization (CRO) providing a variety of technical services including mechanistic enzymology, target validation and characterization, screening and assay development, biomarker development and measurement. The company offers its customers novel approaches to identification of kinase inhibitors along with decades of experience developing clinical candidates for this class. Founders were key scientific leaders in Pfizer's Inflammation Research Unit. Confluence is located at the BioGenerator Accelerator Labs.
| Website | http://confluencelifesciences.com |
| Revenue | $5 million |
| Employees | View employees |
| Founded | 2010 |
| Address | 4340 Duncan Ave Ste 400, St. Louis, Missouri 63110, US |
| Fax | (314) 932-4038 |
| Technologies | |
| Industry | Research Services, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Health Care, Life Science, Medical |
| Competitors | Novartis, AstraZeneca, 百济神州医药信息咨询(上海)有限公司, Emergent BioSolutions, Lengo Therapeutics, CureVac, Loxo@Lilly, AnaptysBio, Infinity Pharmaceuticals, NantKwest +40 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Confluence Life Sciences employee's phone or email?
Confluence Life Sciences Questions
The Confluence Life Sciences annual revenue was $5 million in 2026.
Confluence Life Sciences is based in St. Louis, Missouri.
The NAICS codes for Confluence Life Sciences are [32541, 3254, 325, 32].
The SIC codes for Confluence Life Sciences are [283, 28].
Related Companies
